Document Detail


C-terminal octapeptide of cholecystokinin decreases food intake in obese men.
MedLine Citation:
PMID:  6294699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Six of eight obese men ate significantly less food during an intravenous infusion of the C-terminal octapeptide of cholecystokinin (CCK-8, 4 ng . kg-1 . min-1) than during a saline infusion in a double blind experimental paradigm. Subjects stopped eating sooner during CCK-8. CCK-8 did not change the rate of eating. No overt side effects were reported or observed. This is the first report of the satiety effect of CCK-8 in obese humans and it suggests that the therapeutic potential of CCK-8 for the treatment of obesity deserves investigation.
Authors:
X Pi-Sunyer; H R Kissileff; J Thornton; G P Smith
Related Documents :
22379689 - International conference on harmonisation; final recommendation for the revision of the...
11722569 - Screening of antifeedant activity in brain extracts led to the identification of sulfak...
11457519 - The effect of cholecystokinin in controlling appetite and food intake in humans.
1877689 - Intravenous nutrient-induced satiety depends on feeding-related gut signals.
12920059 - Cholecystokinin and stomach distension combine to reduce food intake in humans.
17135729 - Effects of a preload on reduction of food intake by glp-1 in healthy subjects.
23578759 - Allured or alarmed: counteractive control responses to food temptations in the brain.
3385359 - Recombinant human tumor necrosis factor induces acute reductions in food intake and bod...
9342699 - Disposition of ampicillin in honeybees and hives.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Physiology & behavior     Volume:  29     ISSN:  0031-9384     ISO Abbreviation:  Physiol. Behav.     Publication Date:  1982 Oct 
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0151504     Medline TA:  Physiol Behav     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  627-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Body Weight / drug effects*
Cholecystokinin / therapeutic use*
Eating / drug effects*
Energy Intake / drug effects
Humans
Male
Obesity / drug therapy*
Peptide Fragments / therapeutic use*
Sincalide
Grant Support
ID/Acronym/Agency:
AM 26687/AM/NIADDK NIH HHS; MH 00149/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Peptide Fragments; 25126-32-3/Sincalide; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vagal mediation of the cholecystokinin satiety effect in rats.
Next Document:  Disruption of conditioned taste aversion by the combined effects of LiCl and ECS.